上市公司数据是反映行业发展情况的重要指标。本文深入研究24家医药流通行业上市公司公开披露的2017年年报资料,分析其收入增长、盈利能力、费用控制、资本运作和战略实施的情况,试图发现一些行业变迁的新趋势。
<<The data of listed companies is an important index of industry development.This paper conducts an in-depth study of the 2017 annual data publicly disclosed by 24 listed pharmaceutical circulation companies,by analyzing their income growth,profitability,cost control,capital operation and strategy implementation,in a drive to find the direction of the development and change of Chinese pharmaceutical circulation industry.
<<Keywords: | Listed CompaniesPharmaceutical Circulation IndustryPharmaceutical Retail EnterprisesPharmaceutical Distribution Enterprises |